The role of VWF in FVIII/VWF concentrates: biochemical characterization of three different plasma-derived factor VIII products

被引：0
|
作者：
Cristofaro, Raimondode [1 ]
Lancellotti, Stefano [1 ]
Filippis, Vincenzode [2 ]
Acquasaliente, Laura [2 ]
Valsecchi, Carla [3 ]
Garagiola, Sabella [3 ]
Peyvandi, Flora [3 ]
机构：
[1] Catholic Univ, Sch Med, Haemophilia & Thrombosis Ctr, Dpt Med Sci, Rome, Italy
[2] Univ Padua, Dpt Pharmaceut & Pharmacol Sci, Sch Med, I-35100 Padua, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Switching to low dose of plasma-derived factor VIII/vWF concentrates with Confact®-F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan
    Nagao, A.
    Oka, T.
    Hanabusa, H.
    HAEMOPHILIA, 2015, 21 (05) : E425 - E427
  • [32] The pharmacokinetics and pharmacodynamics of desmopressin (DDAVP): Effect on plasma factor VIII:C (FVIII:C) and von Willebrand's factor (vWF).
    Argenti, D
    Jensen, BK
    Heald, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII63 - PII63
  • [33] ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
    Peyvandi, Flora
    Mannucci, Pier M.
    Valsecchi, Carla
    Pontiggia, Silvia
    Farina, Claudio
    Retzios, Anastassios D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 895 - 898
  • [34] ADAMTS-13 content of plasma-derived factor VIII/von Willebrand factor concentrates
    Kingsland, Sarah
    Feldman, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : 667 - 668
  • [35] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
    MINAMIYAMA, T
    ITO, Y
    OGURI, S
    KOBAYASHI, K
    TAKEDA, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
  • [36] Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development
    Ettingshausen, C. Escuriola
    Kreuz, W.
    HAEMOPHILIA, 2006, 12 : 102 - 106
  • [37] A Phase III, open-label, multicenter study to evaluate pharmacokinetics of a plasma-derived von willebrand factor/factor VIII (VWF/FVIII) concentrate in pediatric subjects with haemophilia A (SWIFTLY-HA STUDY)
    Pompa, M. T.
    Iosava, G.
    Khayat, C.
    Romashevskaya, I
    Aleinikova, O.
    Stasyshyn, O.
    Vashchenko, L.
    Lopez, M. J.
    Seifert, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 582 - 582
  • [38] Plasma-derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study
    Bravo, Maria Isabel
    Perez, Alba
    Raventos, Aida
    Grancha, Salvador
    Jorquera, Juan Ignacio
    Butta, Nora Viviana
    Alvarez-Roman, Maria Teresa
    Costa, Montserrat
    Willis, Todd
    Jimenez-Yuste, Victor
    HAEMOPHILIA, 2022, 28 (05) : 737 - 744
  • [39] ROLE OF FACTOR VIII-VONWILLEBRAND FACTOR (FVIII-VWF) AND FIBRONECTIN (FN) IN PLATELET INTERACTION WITH COLLAGEN IN FLOWING BLOOD
    HOUDIJK, WPM
    SAKARIASSEN, KS
    OTTENHOFROVERS, M
    SIXMA, JJ
    THROMBOSIS AND HAEMOSTASIS, 1983, 50 (01) : 402 - 402
  • [40] Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study)
    Skotnicki, Aleksander
    Lissitchkov, Toshko J.
    Mamonov, Vasily
    Buevich, Evgeny
    Kuliczkowski, Kazimierz
    Goranov, Stefcho
    Kloczko, Janusz
    Klukowska, Anna
    Stankovic, Svetlana
    Gercheva, Liana
    Chernova, Tatiana
    Hellmann, Andrzej
    Dmoszynska, Anna
    Zawilska, Krystyna
    Veldman, Alex
    Joch, Christine
    Seifert, Wilfried
    THROMBOSIS RESEARCH, 2016, 137 : 119 - 125
12345